We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Fast Label-Free Method Identifies Aggressive Cancer Cells

By LabMedica International staff writers
Posted on 29 Jan 2026

Distinguishing aggressive cancer cells from less dangerous ones remains a major clinical challenge, as cells with high metastatic potential often appear similar under standard laboratory conditions. More...

Conventional genetic and molecular tests can be costly, time-consuming, and may fail to capture how likely a cancer is to spread. Metastasis depends not only on gene expression but also on how cancer cells physically interact with their surroundings. Now, a new study shows that aggressive cancer cells can be identified quickly and without labels by observing their physical behavior on specially designed surfaces.

Researchers at the Hebrew University of Jerusalem (Jerusalem, Israel) have developed engineered meta-surfaces patterned with microscopic, immobilized plastic particles that create nano- and micro-scale topographies. These textured surfaces act as mechanical probes, allowing researchers to observe how cancer cells interact physically with their environment.

When cancer cells are placed on these surfaces, they encounter a complex landscape rather than a flat plane. This setup reveals differences in cell adhesion, particle internalization, and shape adaptation. The approach is label-free, does not rely on genetic manipulation or chemical markers, and is compatible with standard imaging and laboratory workflows.

Using the patterned surfaces, the researchers found that aggressive cancer cells grip the surface more strongly, engulf significantly more particles, and stretch and wrap themselves around the microscopic features. Less aggressive cells showed far weaker adhesion and minimal shape changes, despite appearing similar on conventional flat culture surfaces. These functional differences were consistently detectable using the new method.

The study also showed that cells at different stages of metastasis could be distinguished based on their mechanical behavior. Cancer cells temporarily reduced adhesion after leaving the primary tumor and regained strong mechanical interactions upon reaching new sites. The findings, published in Materials Today Bio, demonstrate that cancer aggressiveness is a dynamic functional state rather than a fixed genetic identity.

Measuring how cells physically push, pull, and adhere provides insights into metastatic potential that molecular tests alone may miss. This approach offers a fast, low-cost way to identify high-risk cancer cells and better understand the mechanics of cancer spread. In the future, the technology could support rapid screening of tumor aggressiveness, metastasis research, drug testing, and personalized treatment strategies. Because the surfaces are simple to manufacture and integrate into existing workflows, the method has clear potential for translational and clinical research applications.

“Our work shows that how cancer cells push, pull, and grip their surroundings can tell us a great deal about how dangerous they are,” said Professor Ofra Benny from the School of Pharmacy at the Hebrew University. “This opens a new path for cancer diagnostics that is both powerful and surprisingly simple.”

Related Links:
Hebrew University of Jerusalem


Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.